<?xml version="1.0" encoding="UTF-8"?>
<p>Apart from the specificities related to the origin of the raw material (human biological material), their development and availability, the ATMP are characterized by a great heterogeneity. Indeed, so far a large number of cell populations and tissues have been reported with potential pharmaceutical activity. Also, there is a great variation in methods of isolation, culturing and processing/modification of tissues and cells, whereas the methods of administration cover the entire spectrum from a single intravenous injection to a surgical placement.</p>
